Barclays’s Dermira, Inc. DERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-218,797
| Closed | -$3.32M | – | 6711 |
|
|
2019
Q4 | $3.32M | Sell |
218,797
-166,772
| -43% | -$1.44M | ﹤0.01% | 2453 |
|
|
2019
Q3 | $2.46M | Buy |
385,569
+27,734
| +8% | +$232K | ﹤0.01% | 2614 |
|
|
2019
Q2 | $3.42M | Buy |
357,835
+200,644
| +128% | +$2.16M | ﹤0.01% | 2282 |
|
|
2019
Q1 | $2.13M | Buy |
157,191
+145,685
| +1,266% | +$1.21M | ﹤0.01% | 2502 |
|
|
2018
Q4 | $83K | Sell |
11,506
-1,594
| -12% | -$17.4K | ﹤0.01% | 5164 |
|
|
2018
Q3 | $143K | Buy |
13,100
+9,595
| +274% | +$96.8K | ﹤0.01% | 5264 |
|
|
2018
Q2 | $32K | Sell |
3,505
-13,994
| -80% | -$130K | ﹤0.01% | 5932 |
|
|
2018
Q1 | $140K | Buy |
17,499
+6,454
| +58% | +$141K | ﹤0.01% | 5133 |
|
|
2017
Q4 | $307K | Buy |
11,045
+9,804
| +790% | +$260K | ﹤0.01% | 4321 |
|
|
2017
Q3 | $33K | Buy |
1,241
+927
| +295% | +$24.3K | ﹤0.01% | 5569 |
|
|
2017
Q2 | $9K | Sell |
314
-283
| -47% | -$8.6K | ﹤0.01% | 6100 |
|
|
2017
Q1 | $21K | Sell |
597
-71,335
| -99% | -$2.3M | ﹤0.01% | 5794 |
|
|
2016
Q4 | $2.18M | Buy |
71,932
+22,630
| +46% | +$729K | ﹤0.01% | 2049 |
|
|
2016
Q3 | $1.67M | Buy |
49,302
+3,459
| +8% | +$111K | ﹤0.01% | 2145 |
|
|
2016
Q2 | $1.34M | Buy |
45,843
+45,694
| +30,667% | +$1.26M | ﹤0.01% | 2353 |
|
|
2016
Q1 | $3K | Sell |
149
-1,955
| -93% | -$48K | ﹤0.01% | 5827 |
|
|
2015
Q4 | $72K | Buy |
2,104
+2,023
| +2,498% | +$58.1K | ﹤0.01% | 4602 |
|
|
2015
Q3 | $2K | Sell |
81
-165
| -67% | -$4.01K | ﹤0.01% | 6428 |
|
|
2015
Q2 | $4K | Buy |
246
+10
| +4% | +$154 | ﹤0.01% | 6608 |
|
|
2015
Q1 | $4K | Sell |
236
-209
| -47% | -$3.51K | ﹤0.01% | 6727 |
|
|
2014
Q4 | $8K | Buy |
+445
| New | +$7.44K | ﹤0.01% | 6848 |
|
Barclays's DERM Position: Q1 2020 in Review
Barclays sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 218,797 shares — an estimated $3.32M sold.
Barclays first reported a position in DERM in Q4 2014 and held it in 21 quarters. The position peaked at $3.42M in Q2 2019. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.
- Barclays reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
- Barclays sold 218,797 Dermira, Inc. shares in Q1 2020, an estimated $3.32M.
- Barclays first reported a position in Dermira, Inc. in Q4 2014 and held it in 21 quarters.
- Barclays's Dermira, Inc. position peaked at $3.42M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.
Based on Barclays's 13F filing for Q1 2020, filed 13 May 2020.